With the Trump administration resetting U.S. health policy priorities and the value-based payment model ending its 15th year, the University of Pennsylvania’s Leonard Davis Institute of Health Economics (LDI) hosted a debate between two leading experts over a central question: Has value-based care earned its keep, or is it time to rethink the model?
Part of LDI’s ongoing series of conversations with top policy experts in the health services research field, the November 7 virtual panel featured Farzad Mostashari, MD, MSc, and Andrew Ryan, PhD, in a discussion moderated by LDI Executive Director Rachel M. Werner, MD, PhD. More than 800 leaders in health care, higher education, and government registered for the event.
As she opened the session, Werner noted: “There have been some notable successes in value-based care, along with models that have struggled to deliver meaningful savings or quality gains. But health care spending and costs have continued to rise. With some exceptions, value-based payment has largely not improved access to care or health outcomes for populations with social risk factors, including racial and ethnic minorities, rural populations, and individuals with disabilities.”
“So where does that leave us now?” Werner asked. “The experts we have with us today will help us weigh the pros and cons of value-based payment and its alternatives.”